Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-94.21	15.22	-263.04
Graham Fair Price	500.41	59.00	9.83
PEG	-99.91	< 0.005	2.05
Price/Book	-17.76	2.62	3.19
Price/Cash Flow	-69.70	33.95	112.05
Prices/Earnings	-97.16	6.28	-220.70
Price/Sales	-84.42	11.13	71.45
Price/FCF	-69.70	33.95	112.05
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	23.81	0.71	0.58
Operating Margin	87.52	0.58	-0.31
ROA	3012.26	0.08	< 0.005
ROE	< 0.005	0.10	2791.84
ROIC	< 0.005	0.10	1184.35
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.84	17.89	-95.29
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	-1.23	12.05	882.17
EPS QOQ	-1.08	34.50	3102.10
FCF QOQ	-0.60	2.03	240.06
Revenue QOQ	-0.72	4.89	575.27
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	1741.56	397.17	-77.19
Days Sales Outstanding (DSO)	72.04	6.39	-91.13
Inventory Turnover	0.05	0.23	338.50
Debt/Capitalization	< 0.005	< 0.005	-85.78
Quick Ratio	1.95	2.69	37.97
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	34.48	38.49	11.65
Cash	21.02	23.94	13.90
Capex	-0.21	-0.27	-28.45
Free Cash Flow	0.98	2.97	203.05
Revenue	1.54	9.06	489.24
Naive Interpretation	member

05 - Per Share Metrics · Best

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	3.06	3.99	30.37
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	47.66	-3.43	-92.79
Naive Interpretation	Member

06 - Financial Health · Bad

Rating